Brand P L P, Katan M B
Isala Zwolle, Isala Vrouwkindcentrum, Zwolle.
Ned Tijdschr Geneeskd. 2017;161:D1616.
Taking fish oil supplements in the third trimester of pregnancy was associated with significantly less wheezing or asthma in the child at the age of 3-5 years, according to a randomized clinical trial by Bisgaard et al., NEJM 2017. However, the results of this study should be interpreted with caution. The primary end points were modified at a late stage in the study, and two primary end points, eczema in the first 3 years of life and allergic sensitization at 18 months of age, were demoted to secondary end points, and showed no significant effect of treatment. Furthermore, the age range for the published primary end point, persistent wheeze, differed from that in the protocol. Additional concerns include the emphasis on outcomes by omega-3 fatty acid levels in the blood, a post hoc subgroup analysis not included in the protocol. In our opinion, this study does not justify advising routine fish oil supplements in pregnancy.
根据比斯高尔德等人发表于《新英格兰医学杂志》2017年的一项随机临床试验,孕期第三个阶段服用鱼油补充剂与孩子在3至5岁时出现喘息或哮喘的几率显著降低有关。然而,该研究结果应谨慎解读。研究的主要终点在后期进行了修改,两个主要终点,即生命最初3年的湿疹和18个月大时的过敏致敏,被降为次要终点,且未显示出治疗的显著效果。此外,已发表的主要终点“持续性喘息”的年龄范围与方案中的不同。其他问题包括对血液中ω-3脂肪酸水平结果的强调,这是方案中未包含的事后亚组分析。我们认为,这项研究不足以支持建议孕期常规服用鱼油补充剂。